Infectious Agents and Cancer

unofficial impact factor 2.33

Open Access Research article

Type-specific incidence, clearance and predictors of cervical human papillomavirus infections (HPV) among young women: a prospective study in Uganda

Cecily Banura1,2, Sven Sandin2, Leen-Jan van Doorn3, Wim Quint3, Bernhard Kleter3, Fred Wabwire-Mangen4, Edward K Mbidde5 and Elisabete Weiderpass2,6,7,8*

Author Affiliations

1 College of Health Sciences, Makerere University, Kampala Uganda

2 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

3 DDL Diagnostic Laboratory, Voorburg, the Netherlands

4 School of Public Health, Makerere University, Kampala, Uganda

5 Uganda Virus Research Institute, Entebbe, Uganda

6 Department of Etiological Research, Cancer Registry of Norway, Oslo, Norway

7 Department of Community Medicine, University of Tromso, Tromso, Norway

8 Department of Genetic Epidemiology, Samfundet Folkhalsan, Helsinki, Finland

For all author emails, please log on.

Infectious Agents and Cancer 2010, 5:7 doi:10.1186/1750-9378-5-7

Published: 9 April 2010

Abstract

Background

While infections with human papillomavirus (HPV) are highly prevalent among sexually active young women in Uganda, information on incidence, clearance and their associated risk factors is sparse. To estimate the incidence, prevalence and determinants of HPV infections, we conducted a prospective follow-up study among 1,275 women aged 12-24 years at the time of recruitment. Women answered a questionnaire and underwent a pelvic examination at each visit to collect exfoliated cervical cells. The presence of 42 HPV types was evaluated in exfoliated cervical cells by a polymerase chain based (PCR) assay (SPF10-DEIA LiPA).

Results

Three hundred and eighty (380) of 1,275 (29.8%) women were followed up for a median time of 18.5 months (inter-quartile range 9.7-26.6). Sixty-nine (69) women had incident HPV infections during 226 person-years of follow-up reflecting an incidence rate of 30.5 per 100 person-years. Incident HPV infections were marginally associated with HIV positivity (RR = 2.8, 95% CI: 0.9 - 8.3). Clearance for HPV type-specific infections was frequent ranging between 42.3% and 100.0% for high- and 50% and 100% for low-risk types. Only 31.2% of women cleared all their infections. Clearance was associated with HIV negativity (Adjusted clearance = 0.2, 95% CI: 0.1 - 0.7) but not with age at study entry, lifetime number of sexual partners and multiplicity of infections. The prevalence of low-grade squamous intraepithelial lesions (LSILs) was 53/365 (14.5%). None of the women had a high-grade cervical lesion (HSIL) or cancer. Twenty-two (22) of 150 (14.7%) HPV negative women at baseline developed incident LSIL during follow-up. The risk for LSIL appeared to be elevated among women with HPV 18-related types compared to women not infected with those types (RR = 3.5, 95% CI: 1.0 - 11.8).

Conclusions

Incident HPV infections and type-specific HPV clearance were frequent among our study population of young women. These results underscore the need to vaccinate pre-adolescent girls before initiation of sexual activity.